healthcare News
Kimberly-Clark to Pay $40.4M Over Defective Surgical Gowns
DOJ settlement resolves criminal charge related to the sale of millions of adulterated MicroCool gowns marketed with false safety claims.
Outlook Therapeutics Stock Plummets 54% on FDA Rejection
Regulator denies approval for the company's wet AMD drug Lytenava for a second time, citing a lack of substantial evidence.
Cognition Therapeutics Prices $30M Offering at 28.5% Discount
Clinical-stage biotech raises capital for Phase 3 trials, but new shares will significantly dilute existing stockholders.
BioXcel Plunges 24% as Financial Fears Eclipse Trial Success
Positive Phase 3 data for its agitation drug IGALMI is overshadowed by mounting concerns over cash burn and weak sales.
UnitedHealth Shares Drop as DOJ Broadens Criminal Probe
Investigation expands to include Optum Rx and physician payments, intensifying scrutiny on the healthcare giant.
HCW Biologics Stock Soars on Cancer Immunotherapy Breakthrough
Shares surge over 85% after the company reveals a next-generation cancer drug that outperformed leading treatments in preclinical studies.
AxoGen Nerve Graft Decision Pushed Back by FDA
Regulator extends review for Avance Nerve Graft to December after new manufacturing data requires more time for evaluation.
Moderna Gains Canadian Approval For Updated COVID Vaccine
Health Canada authorizes Spikevax targeting LP.8.1 variant, with all pre-filled syringe doses for 2025 to be produced domestically.